The potential role of oligo-fucoidan as a bioactive adjunct in oncology: a personal view on mechanistic insights and therapeutic continuity.
- DOI
- 10.1016/j.ctarc.2026.101324
- Published
- 2026
- Container
- Cancer treatment and research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101324,
title = {The potential role of oligo-fucoidan as a bioactive adjunct in oncology: a personal view on mechanistic insights and therapeutic continuity.},
author = {Lin KC and Yu JM and Chang CL and Chen WM and Shia BC and Fang CY and Wu SY},
year = {2026},
journal = {Cancer treatment and research communications},
doi = {10.1016/j.ctarc.2026.101324},
url = {https://doi.org/10.1016/j.ctarc.2026.101324}
}RIS
TY - JOUR TI - The potential role of oligo-fucoidan as a bioactive adjunct in oncology: a personal view on mechanistic insights and therapeutic continuity. AU - Lin KC AU - Yu JM AU - Chang CL AU - Chen WM AU - Shia BC AU - Fang CY AU - Wu SY PY - 2026 JO - Cancer treatment and research communications DO - 10.1016/j.ctarc.2026.101324 UR - https://doi.org/10.1016/j.ctarc.2026.101324 ER -
APA
KC, L., JM, Y., CL, C., WM, C., BC, S., CY, F., & SY, W. (2026). The potential role of oligo-fucoidan as a bioactive adjunct in oncology: a personal view on mechanistic insights and therapeutic continuity.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101324
Source records
- pubmed · retrieved 2026-09-25T19:23:24.490Z